1. Home
  2. MSA vs LEGN Comparison

MSA vs LEGN Comparison

Compare MSA & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSA Safety Incorporated

MSA

MSA Safety Incorporated

N/A

Current Price

$183.03

Market Cap

8.0B

Sector

Health Care

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$20.23

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSA
LEGN
Founded
1914
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MSA
LEGN
Price
$183.03
$20.23
Analyst Decision
Buy
Buy
Analyst Count
4
14
Target Price
$193.25
$63.46
AVG Volume (30 Days)
170.2K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.89
$46.27
Revenue Next Year
$4.94
$28.77
P/E Ratio
$28.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$127.86
$16.24
52 Week High
$208.92
$45.30

Technical Indicators

Market Signals
Indicator
MSA
LEGN
Relative Strength Index (RSI) 39.18 60.43
Support Level $165.97 $16.24
Resistance Level $184.20 $21.58
Average True Range (ATR) 4.44 0.91
MACD -2.39 0.25
Stochastic Oscillator 18.74 68.20

Price Performance

Historical Comparison
MSA
LEGN

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: